4-acetamido-3-chloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;4-acetamido-3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-4-methoxybenzamide;methane
C81H85Cl5N14O24 — CID 158717481
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-acetamido-3-chloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;4-acetamido-3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-4-methoxybenzamide;methane
4-acetamido-3-chloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;4-acetamido-3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-4-methoxybenzamide;methane (PubChem CID 158717481) has the molecular formula C81H85Cl5N14O24 and a molecular weight of 1815.91 g/mol. Its IUPAC name is 4-acetamido-3-chloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;4-acetamido-3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-4-methoxybenzamide;methane.
Molecular Properties
| Compound Name | 4-acetamido-3-chloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;4-acetamido-3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-4-methoxybenzamide;methane |
|---|---|
| PubChem CID | 158717481 |
| Molecular Formula | C81H85Cl5N14O24 |
| Molecular Weight | 1815.91 g/mol |
| Exact Mass | 1812.43 |
| IUPAC Name | 4-acetamido-3-chloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;4-acetamido-3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]benzamide;3,5-dichloro-N-[(3S)-5-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-1-(2-hydroxyacetyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-4-methoxybenzamide;methane |
| SMILES | C.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)[C@@H](NC(=O)c2cc(Cl)c(NC(C)=O)c(Cl)c2)CN(C(=O)CO)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)[C@@H](NC(=O)c2ccc(NC(C)=O)c(Cl)c2)CN(C(=O)CO)c2ccccc21.COc1c(Cl)cc(C(=O)N[C@H]2CN(C(=O)CO)c3ccccc3N(CC(=O)N[C@H](C=O)CC(C)=O)C2=O)cc1Cl |
| InChI | InChI=1S/C27H27Cl2N5O8.C27H28ClN5O8.C26H26Cl2N4O8.CH4/c1-14(37)7-17(12-35)31-23(39)11-34-22-6-4-3-5-21(22)33(24(40)13-36)10-20(27(34)42)32-26(41)16-8-18(28)25(19(29)9-16)30-15(2)38;1-15(36)9-18(13-34)30-24(38)12-33-23-6-4-3-5-22(23)32(25(39)14-35)11-21(27(33)41)31-26(40)17-7-8-20(19(28)10-17)29-16(2)37;1-14(35)7-16(12-33)29-22(36)11-32-21-6-4-3-5-20(21)31(23(37)13-34)10-19(26(32)39)30-25(38)15-8-17(27)24(40-2)18(28)9-15;/h3-6,8-9,12,17,20,36H,7,10-11,13H2,1-2H3,(H,30,38)(H,31,39)(H,32,41);3-8,10,13,18,21,35H,9,11-12,14H2,1-2H3,(H,29,37)(H,30,38)(H,31,40);3-6,8-9,12,16,19,34H,7,10-11,13H2,1-2H3,(H,29,36)(H,30,38);1H4/t17-,20-;18-,21-;16-,19-;/m000./s1 |
| InChIKey | IJMPOEDGZHPXBX-QXPGGANTSA-N |
| XLogP | 3.29 |
| TPSA | 527.00 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 124 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1815.91 |
| LogP ≤ 5 | 3.29 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 24 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158717481 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.